Fred Van Leuven

Dr. van Leuven is Professor at the Catholic University of Leuven, faculty of medicine. He received his Ph.D. in biochemistry from the University of Ghent. Prof. van Leuven is well-known for his work on neurodegenerative diseases and transgenic animals, in particular for developing several transgenic mice that are models for the amyloid plaques and neurofibrillary tangles of Alzheimer's disease. He is co-founder of the KULeuven spin-off reMYND nv, a privately owned biotech company dedicated to the development and exploitation of pre-clinical mouse and yeast models for Alzheimer's and Parkinson's disease.